How it works:
The trial will aim to give terminally ill patients a new perspective on their lives, during the final stage.
The administration will have to be guided by the hospital psychiatrist, under the guidelines of removing fear and depression from a dying patient.
Ask the expert:
Dr Margaret Ross, Clinical Psychologist at St Vincents Hospital.
“The studies would see patients given a single dose of psilocybin, which is so powerful it can unlock a section of a patient’s brains to give them an altered outlook on their situation approaching death.”
The details:
The trial has taken more than a year to gain approval by ethics committees as well as federal and state authorities
